Preclinical 89Zr-Immunopet of High Grade Serous Ovarian Cancer and Lymph Node Metastasis Sai Kiran Sharma1,3, Kuntal K
Journal of Nuclear Medicine, published on February 2, 2016 as doi:10.2967/jnumed.115.167072 Preclinical 89Zr-immunoPET of High Grade Serous Ovarian Cancer and Lymph Node Metastasis Sai Kiran Sharma1,3, Kuntal K. Sevak1, Sebastien Monette2, Sean D. Carlin1, James C. Knight3, Frank R. Wuest3, Evis Sala4, Brian M. Zeglis5,*, Jason S. Lewis1,* 1 Department of Radiology and the Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, NY, USA 2 Tri-Institutional Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and The Rockefeller University, NY, USA 3 Department of Oncology, University of Alberta, AB, Canada 4 Department of Radiology, Memorial Sloan Kettering Cancer Center, NY, USA 5 Department of Chemistry, Hunter College and the Graduate Center of the City University of New York, NY, USA First Author: Sai Kiran Sharma, Department of Radiology, Zuckerman Research Center, 417 East 68th Street, 394, New York, NY, 10065, USA Email: sharmas@mskcc.org Phone: +1.212.896.0484. Fax: +1.646.888.3059 *Co-Corresponding Authors: Brian M. Zeglis, Department of Chemistry, Hunter College and the Graduate Center of the City University of New York, NY, 10021, USA Email: bz102@hunter.cuny.edu Phone: +1.212.896.0443. Fax: +1.212.772.5332 Jason S. Lewis, Department of Radiology, 1275 York Avenue, Memorial Sloan Kettering Cancer Center, NY, 10065, USA Email: lewisj2@mskcc.org Phone: +1.646.888.3038. Fax: +1.646.888.3059 1 Financial Support: The authors gratefully acknowledge the MSKCC Small Animal Imaging Core Facility, which is supported in part by NIH grant P30 CA08748.
[Show full text]